Concepedia

Louis Matty

LM

10

Publications

563

Citations

10

H-Index

1980

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

ExxonMobil (United States)

Louis Matty is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in chemistry, organic chemistry, and pharmacology.

Top concepts

ChemistryOrganic ChemistryEngineeringPharmacologyMedicineDrug DiscoveryChemical EngineeringGrapheneCatalysisBiochemistry

Publications per year

1980–2005

10

Publications

10

Are Heterogeneous Catalysts Precursors to Homogeneous Catalysts?

Ian W. Davies, Louis Matty, David L. Hughes et al. · Journal of the American Chemical Society · 2001 · 325 citations

Materials Science, Chemical Engineering, Engineering +10

A Concise Synthesis of a Novel Antiangiogenic Tyrosine Kinase Inhibitor

Joseph F. Payack, Enrique Vázquez, Louis Matty et al. · The Journal of Organic Chemistry · 2004 · 55 citations

Concise Synthesis, Medicinal Chemistry, Novel Therapy +12

Stereoselective Synthesis of a Potent Thrombin Inhibitor by a Novel P2−P3 Lactone Ring Opening

Todd D. Nelson, Carl LeBlond, Doug E. Frantz et al. · The Journal of Organic Chemistry · 2004 · 49 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Bioorganic Chemistry +13

The interrelationship of graphite intercalation compounds, ions of aromatic hydrocarbons, and coal conversion

Lawrence B. Ebert, Louis Matty · Materials Research Bulletin · 1980 · 26 citations

Materials Science, Graphene Nanomeshes, Chemical Engineering +9

An Efficient Synthesis of a Dual PPAR α/γ Agonist and the Formation of a Sterically Congested α-Aryloxyisobutyric Acid via a Bargellini Reaction

Raymond J. Cvetovich, John Y. L. Chung, Michael H. Kress et al. · The Journal of Organic Chemistry · 2005 · 22 citations

Chemical Engineering, Novel Organocatalysts, Benzisoxazole 1 +13

Rows per page

1–5 of 10